Abdykadyrov Mazhit
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abdykadyrov Mazhit has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Abylai Baymakhanov
Faculty of Postgraduate Education, JSC «Asfendiyarov Kazakh National Medical University», Almaty, Kazakhstan
1 shared publication - Almas Ismailov
City Multidisciplinary Hospital No. 2, Astana 010000, Kazakhstan
1 shared publication - Aman Berkinbay
Kazakh National Medical University
1 shared publication - Berik Dzhumabekov
Department of Medicine, Al-Farabi Kazakh National University, Almaty 050000, Kazakhstan
1 shared publication - Dias Myrzash
JSC «Asfendiyarov Kazakh National Medical University», Almaty, the Republic of Kazakhstan
1 shared publication - E.S. Tulebaev
NJC “Kazakh National Medical University named after S.D. Asfendiyarov”, Almaty, Republic of Kazakhstan
1 shared publication
Latest Publications
- Open Access
- 20 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3126
Clinical Outcomes and Complications of Endoscopic Biliary Stenting for Malignant Distal Biliary Obstruction in Pancreatic Cancer: A Systematic Review
Background/Objectives: Malignant distal biliary obstruction (MDBO) is a frequent complication of pancreatic cancer and often leads to obstructive jaundice, impaired liver function, and delayed oncologic treatment. Endoscopic biliary drainage using endoscopic retrograde cholangiopancreatography (ERCP) with stent placement is the standard minimally invasive approach for restoring biliary flow. However, clinical outcomes and complication rates vary across studies depending on stent design, placement technique, and patient characteristics. The aim of this systematic review was to evaluate the clinical outcomes and complications associated with endoscopic biliary stenting in pancreatic cancer-related MDBO. Methods: A systematic literature search was performed in PubMed/MEDLINE, ScienceDirect, Web of Science, and the Cochrane Library for studies published between January 2016 and January 2026. Studies evaluating ERCP-guided biliary stenting in adult patients with pancreatic cancer-related malignant distal biliary obstruction were included. Study selection followed PRISMA 2020 guidelines, and methodological quality was assessed using the Newcastle–Ottawa Scale. Clinical outcomes including technical success, clinical success, stent patency, recurrent biliary obstruction, and procedure-related complications were analyzed. Results: Eighteen studies involving a total of 3291 patients were included in the qualitative synthesis. Technical success rates were consistently high, reaching up to 100% in several studies, while clinical success rates generally exceeded 90%. Median time to recurrent biliary obstruction ranged from approximately 102 to 541 days depending on stent type and placement technique. Recurrent biliary obstruction was the most frequently reported complication, occurring in 30.7% of patients. Stent migration occurred in 14.9% of cases, while post-ERCP pancreatitis was reported in approximately 4.2% of patients. Several studies demonstrated longer patency with self-expandable metal stents compared with plastic stents. Conclusions: Endoscopic biliary stenting performed during ERCP is an effective and safe strategy for the management of malignant distal biliary obstruction in pancreatic cancer. Self-expandable metal stents provide more durable biliary drainage and reduce the need for repeat interventions. Nevertheless, recurrent biliary obstruction remains a common limitation, highlighting the need for further improvements in stent technology and optimized placement strategies.
- 20 April 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (8) , 3126
Open AccessClinical Outcomes and Complications of Endoscopic Biliary Stenting for Malignant Distal Biliary Obstruction in Pancreatic Cancer: A Systematic Review
Background/Objectives: Malignant distal biliary obstruction (MDBO) is a frequent complication of pancreatic cancer and often leads to obstructive jaundice, impaired liver function, and delayed oncologic treatment. Endoscopic biliary drainage using endoscopic retrograde cholangiopancreatography (ERCP) with stent placement is the standard minimally invasive approach for restoring biliary flow. However, clinical outcomes and complication rates vary across studies depending on stent design, placement technique, and patient characteristics. The aim of this systematic review was to evaluate the clinical outcomes and complications associated with endoscopic biliary stenting in pancreatic cancer-related MDBO. Methods: A systematic literature search was performed in PubMed/MEDLINE, ScienceDirect, Web of Science, and the Cochrane Library for studies published between January 2016 and January 2026. Studies evaluating ERCP-guided biliary stenting in adult patients with pancreatic cancer-related malignant distal biliary obstruction were included. Study selection followed PRISMA 2020 guidelines, and methodological quality was assessed using the Newcastle–Ottawa Scale. Clinical outcomes including technical success, clinical success, stent patency, recurrent biliary obstruction, and procedure-related complications were analyzed. Results: Eighteen studies involving a total of 3291 patients were included in the qualitative synthesis. Technical success rates were consistently high, reaching up to 100% in several studies, while clinical success rates generally exceeded 90%. Median time to recurrent biliary obstruction ranged from approximately 102 to 541 days depending on stent type and placement technique. Recurrent biliary obstruction was the most frequently reported complication, occurring in 30.7% of patients. Stent migration occurred in 14.9% of cases, while post-ERCP pancreatitis was reported in approximately 4.2% of patients. Several studies demonstrated longer patency with self-expandable metal stents compared with plastic stents. Conclusions: Endoscopic biliary stenting performed during ERCP is an effective and safe strategy for the management of malignant distal biliary obstruction in pancreatic cancer. Self-expandable metal stents provide more durable biliary drainage and reduce the need for repeat interventions. Nevertheless, recurrent biliary obstruction remains a common limitation, highlighting the need for further improvements in stent technology and optimized placement strategies.
- Open Access
- 30 June 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(27),p. 143-150
ANALYSIS OF TREATMENT OUTCOMES FOR BLEEDING FROM ESOPHAGEAL AND GASTRIC VARICES
Introduction.Bleedingfromesophagealandgastricvarices(EGV)isoneofthemostlife-threateningcomplicationsoflivercirrhosisandportalhypertension,associatedwithhighmortality,especiallyincasesoflatediagnosisandadvancedhepaticinsufficiency. Aim.ToevaluatetheclinicalcharacteristicsandtreatmentoutcomesofpatientswithEGVbleedingtreatedattheSurgicalDepartmentoftheEmergencyCityHospitalinAlmatyfrom2022to2024. MaterialsandMethods.Тhestudyincluded162patients.Clinicalparameters,severityofcirrhosis(Child–Pughscore),MELDindex,endoscopicclassificationofvarices(JGES),andtreatmentoutcomeswereanalyzed.Descriptivestatistics,Student’st-test,χ²-test,andone-wayANOVAwereused.Oddsratios(OR)with95%confidenceintervalswerecalculatedtoassessriskfactorsforrebleeding.Ap-value<0.05wasconsideredstatisticallysignificant. Results.Among162patients,malespredominated(55.6%),withameanageof54.3 ± 11.2years.Anemia(<70g/L)wasdetectedin62.3%.II–IIIdegreevariceswerediagnosedin95.1%,andChild–PughclassesBandCwerepresentin69.7%.Earlyligation(<24hours)reducedrebleedingto2.3%,comparedto12.5%withdelayedintervention(OR = 2.32);presenceofredcolorsigns(RCS)increasedrebleedingriskto17.9%(OR = 6.51).Overallmortalitywas4.32%,postoperativemortality—1.2%;allfataloutcomesoccurredinpatientswithseverehepaticdysfunction.Conclusions.EGVbleedingremainsaseverecomplicationofcirrhosisrequiringpromptdiagnosisandactivetreatment.Earlyendoscopicligationeffectivelyreducestheriskofrebleedingandmortality.ThepresenceofRCSandadvancedvaricealgradearesignificantpredictorsofpoorprognosis. Введение. Кровотечение из варикозно-расширенных вен (ВРВ) пищевода и желудка является одним из наиболее опасных осложнений цирроза печени и портальной гипертензии, сопровождающимся высокой летальностью при поздней диагностике и тяжёлой печёночной недостаточности. Цель. Оценить клинические характеристики и результаты лечения пациентов с кровотечением из ВРВ пищевода и желудка, пролеченных в хирургическом отделении ГБСНП г. Алматы в 2022–2024 гг. Материалы и методы. В исследование включены 162 пациента. Изучены клинические данные, тяжесть цирроза по шкале Child–Pugh, уровень MELD, эндоскопическая характеристика ВРВ (по классификации JGES), результатов лечения.Применялись методы описательной статистики, t-критерий Стьюдента, χ²-тест, однофакторный ANOVA. Для оценки факторов риска рецидива кровотечения рассчитывались отношения шансов (OR) с 95% доверительными интервалами. Значение p< 0,05 считалось статистически значимым. Результаты.Среди 162 пациентов с ВРВ пищевода и желудка преобладали мужчины (55,6%), средний возраст — 54,3 ± 11,2 лет. У 62,3% пациентоввыявленаанемия(<70 г/л). II–IIIстепеньВРВдиагностированау 95,1%, классыBиCпоChild–Pugh—у 69,7%. Раннеелигирование (<24 ч) снижалорецидивдо 2,3%, при≥24 ч—до 12,5% (OR = 2,32); наличиекрасных маркеров (RCS) повышало риск рецидива до 17,9% (OR = 6,51). Общаялетальностьсоставила4,32%, послеоперационная— 1,2%; всеслучаилетальногоисходазарегистрированыпритяжёлойпечёночнойнедостаточности. Выводы:Кровотечение из ВРВ пищевода и желудка требует своевременной диагностики и активной тактики. Раннее эндоскопическое лигирование эффективно снижает риск рецидива и летальности. Наличие RCS и IIIстепень ВРВ являются значимыми предикторами неблагоприятного течения. Кіріспе.Өңешпенасқазанныңварикоздыкеңейгенвеналарынан (ВКВ) туындайтынқанкету—бауырциррозыменпортальдыгипертензияныңеңқауіптіасқынуларыныңбірі. Бұлжағдай, әсіреседиагноздыңкешқойылуындажәнебауырқызметініңауыржеткіліксіздігі кезінде, жоғарыөлім-жітімменсипатталады. Мақсаты. Алматы қалалықжеделшұғылкөмеккөрсетуауруханасыхирургиябөлімінде 2022–2024 жылдараралығындаВКВ-нанқанкетудиагнозыменемделгеннауқастардыңклиникалықсипаттамаларынжәнеемдеунәтижелерінбағалау. Материалдар мен тәсілдер. Зерттеуге ВКВ-нан қанкеткен 162 науқасенгізілді. Клиникалықдеректер, цирроздыңауырлығы (Child–Pugh шкаласыбойынша), MELD индексі, эндоскопиялықжіктеу (JGES), емдеунәтижелерізерттелді. Деректергесипаттамалықстатистика, Стьюденттің...
- 30 June 2025
- Published by Semey Medical University in Наука и здравоохранение
- No. 3(27),p. 143-150
Open AccessANALYSIS OF TREATMENT OUTCOMES FOR BLEEDING FROM ESOPHAGEAL AND GASTRIC VARICES
Introduction.Bleedingfromesophagealandgastricvarices(EGV)isoneofthemostlife-threateningcomplicationsoflivercirrhosisandportalhypertension,associatedwithhighmortality,especiallyincasesoflatediagnosisandadvancedhepaticinsufficiency. Aim.ToevaluatetheclinicalcharacteristicsandtreatmentoutcomesofpatientswithEGVbleedingtreatedattheSurgicalDepartmentoftheEmergencyCityHospitalinAlmatyfrom2022to2024. MaterialsandMethods.Тhestudyincluded162patients.Clinicalparameters,severityofcirrhosis(Child–Pughscore),MELDindex,endoscopicclassificationofvarices(JGES),andtreatmentoutcomeswereanalyzed.Descriptivestatistics,Student’st-test,χ²-test,andone-wayANOVAwereused.Oddsratios(OR)with95%confidenceintervalswerecalculatedtoassessriskfactorsforrebleeding.Ap-value<0.05wasconsideredstatisticallysignificant. Results.Among162patients,malespredominated(55.6%),withameanageof54.3 ± 11.2years.Anemia(<70g/L)wasdetectedin62.3%.II–IIIdegreevariceswerediagnosedin95.1%,andChild–PughclassesBandCwerepresentin69.7%.Earlyligation(<24hours)reducedrebleedingto2.3%,comparedto12.5%withdelayedintervention(OR = 2.32);presenceofredcolorsigns(RCS)increasedrebleedingriskto17.9%(OR = 6.51).Overallmortalitywas4.32%,postoperativemortality—1.2%;allfataloutcomesoccurredinpatientswithseverehepaticdysfunction.Conclusions.EGVbleedingremainsaseverecomplicationofcirrhosisrequiringpromptdiagnosisandactivetreatment.Earlyendoscopicligationeffectivelyreducestheriskofrebleedingandmortality.ThepresenceofRCSandadvancedvaricealgradearesignificantpredictorsofpoorprognosis. Введение. Кровотечение из варикозно-расширенных вен (ВРВ) пищевода и желудка является одним из наиболее опасных осложнений цирроза печени и портальной гипертензии, сопровождающимся высокой летальностью при поздней диагностике и тяжёлой печёночной недостаточности. Цель. Оценить клинические характеристики и результаты лечения пациентов с кровотечением из ВРВ пищевода и желудка, пролеченных в хирургическом отделении ГБСНП г. Алматы в 2022–2024 гг. Материалы и методы. В исследование включены 162 пациента. Изучены клинические данные, тяжесть цирроза по шкале Child–Pugh, уровень MELD, эндоскопическая характеристика ВРВ (по классификации JGES), результатов лечения.Применялись методы описательной статистики, t-критерий Стьюдента, χ²-тест, однофакторный ANOVA. Для оценки факторов риска рецидива кровотечения рассчитывались отношения шансов (OR) с 95% доверительными интервалами. Значение p< 0,05 считалось статистически значимым. Результаты.Среди 162 пациентов с ВРВ пищевода и желудка преобладали мужчины (55,6%), средний возраст — 54,3 ± 11,2 лет. У 62,3% пациентоввыявленаанемия(<70 г/л). II–IIIстепеньВРВдиагностированау 95,1%, классыBиCпоChild–Pugh—у 69,7%. Раннеелигирование (<24 ч) снижалорецидивдо 2,3%, при≥24 ч—до 12,5% (OR = 2,32); наличиекрасных маркеров (RCS) повышало риск рецидива до 17,9% (OR = 6,51). Общаялетальностьсоставила4,32%, послеоперационная— 1,2%; всеслучаилетальногоисходазарегистрированыпритяжёлойпечёночнойнедостаточности. Выводы:Кровотечение из ВРВ пищевода и желудка требует своевременной диагностики и активной тактики. Раннее эндоскопическое лигирование эффективно снижает риск рецидива и летальности. Наличие RCS и IIIстепень ВРВ являются значимыми предикторами неблагоприятного течения. Кіріспе.Өңешпенасқазанныңварикоздыкеңейгенвеналарынан (ВКВ) туындайтынқанкету—бауырциррозыменпортальдыгипертензияныңеңқауіптіасқынуларыныңбірі. Бұлжағдай, әсіреседиагноздыңкешқойылуындажәнебауырқызметініңауыржеткіліксіздігі кезінде, жоғарыөлім-жітімменсипатталады. Мақсаты. Алматы қалалықжеделшұғылкөмеккөрсетуауруханасыхирургиябөлімінде 2022–2024 жылдараралығындаВКВ-нанқанкетудиагнозыменемделгеннауқастардыңклиникалықсипаттамаларынжәнеемдеунәтижелерінбағалау. Материалдар мен тәсілдер. Зерттеуге ВКВ-нан қанкеткен 162 науқасенгізілді. Клиникалықдеректер, цирроздыңауырлығы (Child–Pugh шкаласыбойынша), MELD индексі, эндоскопиялықжіктеу (JGES), емдеунәтижелерізерттелді. Деректергесипаттамалықстатистика, Стьюденттің...